Effects of Cerebrolysin on Motor Recovery in Patients With Subacute Stroke "E-COMPASS"


Phase 4 Results N/A

Summary of Purpose

This study, E-COMPASS is a phase IV clinical trial designed as a multicenter, randomized, double-blind, placebo-controlled, parallel-group study. This study will enroll 75 subacute stroke patients with unilateral motor dysfunction. Primary objective is to demonstrate the efficacy of porcine brain peptide to improve motor recovery measured by the improvement ratio of Fugl-Meyer assessment ((score of FMA after 3...

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 10 May 2016.

1 Jan 2011 5 Nov 2013 1 Jan 2014 1 Feb 2014 1 May 2016 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics




Trial Design

  • Allocation: Randomized
  • Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor)
  • Purpose: Treatment
  • Endpoint: Safety/Efficacy Study
  • Intervention: Parallel Assignment